Howard Maibach, MD

A preliminary report of the occupation of patients evaluated in patch test clinics. (11381341)

Rietschel RL, Mathias CG, Taylor JS, Storrs FJ, Sherertz EF, Pratt M, Marks JG, Maibach HI, Fransway AF, Fowler JF, DeLeo VA, Belsito DV PMID: 11381341

Alefacept (Biogen). (11569937)

Bashir SJ, Maibach HI PMID: 11569937

Skin occlusion and irritant and allergic contact dermatitis: an overview. (11260234)

Zhai H, Maibach HI PMID: 11260234

Gold allergy in North America. (11244133)

Fowler J, Taylor J, Storrs F, Sherertz E, Rietschel R, Pratt M, Mathias CG, Marks J, Maibach H, Fransway A, DeLeo V, Belsito D PMID: 11244133

Is contact allergy in man lifelong? An overview of patch test follow-ups. (11217984)

Lee EE, Maibach HI PMID: 11217984

Pitfalls of irritant patch testing using different test chamber sizes. (11244137)

Löffler H, Freyschmidt-Paul P, Effendy I, Maibach HI PMID: 11244137

Subclinical, non-erythematous irritation with an open assay model (washing): sodium lauryl sulfate (SLS) versus sodium laureth sulfate (SLES). (11278060)

Charbonnier V, Morrison BM, Paye M, Maibach HI PMID: 11278060

Chemical load as a factor in skin sensitization risk assessment: rodent versus man. (11205398)

Anigbogu AN, Maibach HI PMID: 11205398

Physical and physiological effects of stratum corneum tape stripping. (11301640)

Bashir SJ, Chew AL, Anigbogu A, Dreher F, Maibach HI PMID: 11301640

Sea water or its components alter experimental irritant dermatitis in man. (11301639)

Yoshizawa Y, Tanojo H, Kim SJ, Maibach HI PMID: 11301639